- Home
- MGN vs ICCM Comparison
MGN vs ICCM Comparison
Compare MGN & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | MGN | ICCM |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | Malaysia | Israel |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6M | 43.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | MGN | ICCM |
|---|---|---|
| Price | $3.50 | $0.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | ★ 1.1M | 204.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | N/A | $31.38 |
| P/E Ratio | $32.33 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $0.54 |
| 52 Week High | $3.99 | $1.50 |
Technical Indicators
Market Signals| Indicator | MGN | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 74.46 | 52.94 |
| Support Level | $1.42 | $0.58 |
| Resistance Level | N/A | $0.74 |
| Average True Range (ATR) | 0.50 | 0.05 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 99.24 | 47.68 |
Price Performance
Historical ComparisonAbout MGN Megan Holdings Limited Ordinary Shares
Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.